Oncimmune

Oncimmune has a direct presence in 2 countries.

Acquisition, funding and merger involving Oncimmune.

• Freenome has announced the acquisition of Oncimmune  (posted on May 23 2023).

View the org chart displaying its 12 main executives

Most searched biographies at Oncimmune

• Martin Gouldstone, Chief Executive Officer and Director
• Annalisa Jenkins, Director
• John Goold, Non-Executive Director

Create your alert
to follow the executive moves at Oncimmune.

Oncimmune has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Oncimmune

• https://oncimmune.com/wp-content/uploads/2019/09/190906-ECLS-World-Lung-press-release-FINAL.pdf
• http://oncimmune.com/wp-content/uploads/FINAL-IASLC-Press-Release-25-Sept-2018.pdf

Social media about Oncimmune

• Oncimmune on Wikipedia, Google News & Yahoo Finance
• Oncimmune on LinkedIn, Twitter & YouTube

Contact by email its executives including John Goold

Call Oncimmune at +44 115...

View the org chart

Register to receive your alert

Report an error